See how top analysts and institutions rate MRVL — including buy, hold, and sell recommendations.
| Rating Source | Action | Rating | Target Price | Updated |
|---|---|---|---|---|
| Barclays | Downgrade | Overweight → Equal Weight | $80 | 2025-10-20 |
| TD Cowen | Downgrade | Buy → Hold | $85 | 2025-10-01 |
| BofA Securities | Downgrade | Buy → Neutral | $78 | 2025-08-29 |
| Needham | Reiterated | Buy | $85 → $80 | 2025-08-29 |
| Goldman | Initiated | Neutral | $75 | 2025-07-10 |
| China Renaissance | Initiated | Buy | 2025-06-05 | |
| TD Cowen | Reiterated | Buy | $60 → $70 | 2025-05-30 |
| Redburn Atlantic | Initiated | Neutral | $67 | 2025-05-28 |
| Melius | Downgrade | Buy → Hold | $66 | 2025-05-22 |
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|
| November 2025 | 6 | 22 | 12 | 0 | 0 |
| October 2025 | 7 | 24 | 11 | 0 | 0 |
| September 2025 | 7 | 25 | 10 | 0 | 0 |
| July 2025 | 8 | 27 | 7 | 0 | 0 |
The majority of institutional investors have issued a "Buy" rating for MRVL, and analyst sentiment aligns closely, with very few "Sell" recommendations. This suggests a broadly favorable outlook for the stock's performance.
